Company intelligence / Profile preview

Continuity Pharma

West Lafayette, Indiana, United Statescontinuitypharma.com ↗

Ownership: Private
Development stage: Commercial

Overview

Continuity Pharma has developed and commercialized continuous flow manufacturing processes for several essential small molecule medicines, including lomustine. The company’s technology enables rapid optimization and scalable production of high-quality active pharmaceutical ingredients with improved sustainability, efficiency, and supply chain resilience. It has received DARPA funding to advance US-based generic drug manufacturing.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Drug pipeline

1 asset

lomustine

Commercial

Indications: Glioblastoma

Partnerships

DARPAFDA Emerging Technology Program member/partner

Beyond the preview

Go deeper on Continuity Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Continuity Pharma.

Explore the full profile